Company | Name | Exchange | Sector | Industry | Analyst Recommendation | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astra Indust | Saudi Arabia | Healthcare | Pharmaceuticals | 2 | SAR 1.32KCr | 22.3x | 1 | SAR 164 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.9% Upside | Upgrade to Pro+ | |
Dr Sulaiman | Saudi Arabia | Healthcare | Healthcare Providers & Services | 2 | SAR 9.54KCr | 43.3x | 3.1 | SAR 268.80 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.6% Upside | Upgrade to Pro+ | |
Middle East Pharmaceutical | Saudi Arabia | Healthcare | Pharmaceuticals | 2 | SAR 266Cr | 33.3x | 0.33 | SAR 133.20 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -7.9% Downside | Upgrade to Pro+ | |
Care | Saudi Arabia | Healthcare | Healthcare Providers & Services | 2 | SAR 723Cr | 24.3x | 1.04 | SAR 161 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25% Upside | Upgrade to Pro+ | |
Al Hammadi Co | Saudi Arabia | Healthcare | Healthcare Providers & Services | 2.33 | SAR 660Cr | 19.3x | 1.61 | SAR 41.30 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.4% Upside | Upgrade to Pro+ |